Case number 1:23-cv-00623
Horizon Therapeutics USA Inc. et al v. Dr. Reddys Laboratories, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 15, 2023 | 32 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of Dismissal)(mdb) (Entered: 12/15/2023) (0) |
| Dec 15, 2023 | 31 | SO ORDERED, re 30 Stipulation of Dismissal of Action with Prejudice filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC, ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 12/15/2023. (mdb) (Entered: 12/15/2023) (2) |
| Dec 15, 2023 | 30 | STIPULATION of Dismissal of Action with Prejudice by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Dellinger, Megan) Modified on 12/15/2023 (mdb). (Entered: 12/15/2023) (2) |
| Nov 20, 2023 | 29 | STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 11/20/2023. (dlw) (Entered: 11/20/2023) (25) |
| Nov 20, 2023 | 28 | Joint PROPOSED ORDER -- Stipulated Protective Order -- by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Dellinger, Megan) (Entered: 11/20/2023) (25) |
| Nov 6, 2023 | 27 | NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); (2) Plaintiffs' Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery; and (3) Plaintiffs' Disclosures Pursuant to Paragraph 4 of the District of Delaware Default Standard for Discovery filed by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc..(Dellinger, Megan) (Entered: 11/06/2023) (3) |
| Nov 6, 2023 | 26 | NOTICE OF SERVICE of (i) Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, and, (ii) Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Initial Disclosures Pursuant to Rule 26(a)(1) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Gattuso, Dominick) (Entered: 11/06/2023) (2) |
| Nov 2, 2023 | 25 | STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to November 20, 2023 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Gattuso, Dominick) (Entered: 11/02/2023) (2) |
| Oct 10, 2023 | 24 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc. filed by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Dellinger, Megan) (Entered: 10/10/2023) (2) |
| Oct 6, 2023 | 23 | NOTICE OF SUBSTITUTION OF COUNSEL re Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.: Entry of appearance of attorney Jack B. Blumenfeld. Attorney Karen E. Keller, Nathan R. Hoeschen, and the law firm Shaw Keller LLP terminated. (Blumenfeld, Jack) (Entered: 10/06/2023) (2) |
| Oct 4, 2023 | 22 | NOTICE OF SERVICE of Produced Documents filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Gattuso, Dominick) (Entered: 10/04/2023) (2) |
| Sep 25, 2023 | 21 | SO ORDERED re 20 Joint STIPULATION TO EXTEND TIME to Exchange Disclosures and Submit a Proposed Protective Order to November 6, 2023. Signed by Judge Maryellen Noreika on 9/25/2023. (dlw) (Entered: 09/25/2023) (2) |
| Sep 22, 2023 | 20 | Joint STIPULATION TO EXTEND TIME to Exchange Dislcosures and Submit a Proposed Protective Order to November 6, 2023 - filed by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Hoeschen, Nathan) (Entered: 09/22/2023) (2) |
| Aug 24, 2023 | 19 | SCHEDULING ORDER: Joinder of Parties due by 4/2/2024. Amended Pleadings due by 4/2/2024. Fact Discovery completed by 3/14/2024. Opening Expert Reports due by 9/11/2024. Rebuttal Expert Reports due by 10/25/2024. Reply Expert Reports due by 11/15/2024. Expert Discovery due by 12/13/2024. Claim Construction Opening Brief served by 4/25/2024. Claim Construction Answering Brief served by 5/23/2024. Claim Construction Reply Brief served by 6/13/2024. Claim Construction Surreply Brief served by 6/27/2024. Joint Claim Construction Brief filed by 7/2/2024. A Markman Hearing is set for 7/29/2024 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 2/26/2025 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 3-day Bench Trial is set for 3/5/2025 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 8/24/2023. (dlw) (Entered: 08/24/2023) (12) |
| Aug 23, 2023 | 18 | PROPOSED ORDER -- Scheduling Order by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Hoeschen, Nathan) (Entered: 08/23/2023) (12) |
| Aug 15, 2023 | 17 | STIPULATION TO EXTEND TIME to submit a Proposed Scheduling Order to August 23, 2023 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Gattuso, Dominick) (Entered: 08/15/2023) (2) |
| Aug 4, 2023 | 16 | ANSWER to 12 Answer to Complaint, Counterclaims by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc..(DiBenedetto, Emily) Modified on 8/4/2023 (mdb). (Entered: 08/04/2023) (11) |
| Jul 17, 2023 | 15 | ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. The bench trial in this matter will be set for 3/5/2025. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiffs serves their opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 7/17/2023. (dlw) (Entered: 07/17/2023) (0) |
| Jul 17, 2023 | 14 | NOTICE OF SERVICE of Dr. Reddy's Laboratories' Abbreviated New Drug Application, bearing Bates numbers(0000001DRL-PRED-0028333) [HIGHLY CONFIDENTIAL] filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Gattuso, Dominick) (Entered: 07/17/2023) (2) |
| Jul 14, 2023 | 12 | ANSWER to 1 Complaint, , COUNTERCLAIM against All Plaintiffs by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Gattuso, Dominick) (Entered: 07/14/2023) (21) |
| Jul 14, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Gattuso, Dominick) (Entered: 07/14/2023) (2) |
| Jun 29, 2023 | N/A | Pro Hac Vice Attorney Jonathan R. Davies, Daniel J. Knauss, Kyung Taeck Minn, and Sanya Sukduang for Horizon Therapeutics USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/29/2023) (0) |
| Jun 28, 2023 | N/A | SO ORDERED re 11 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Daniel Knauss and Kyung Taeck Minn filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC. ORDERED by Judge Maryellen Noreika on 6/28/2023. (dlw) (Entered: 06/28/2023) (0) |
| Jun 28, 2023 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Daniel Knauss and Kyung Taeck Minn - filed by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Keller, Karen) (Entered: 06/28/2023) (7) |
| Jun 20, 2023 | N/A | Pro Hac Vice Attorney Jovial Wong for Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/20/2023) (0) |
| Jun 16, 2023 | N/A | Pro Hac Vice Attorney Brian O'Gara for Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/16/2023) (0) |
| Jun 16, 2023 | N/A | SO ORDERED re 10 MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong and Brian L. O'Gara of Winston & Strawn LLP filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ORDERED by Judge Maryellen Noreika on 6/16/2023. (dlw) (Entered: 06/16/2023) (0) |
| Jun 16, 2023 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong and Brian L. O'Gara of Winston & Strawn LLP - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Gattuso, Dominick) (Entered: 06/16/2023) (4) |
| Jun 16, 2023 | 9 | SO ORDERED re 7 Stipulation Waiving Service and Setting Deadline to Respond to Complaint (Set/Reset Answer Deadlines: Dr. Reddys Laboratories, Inc. answer due 7/14/2023; Dr. Reddys Laboratories, Ltd. answer due 7/14/2023). Signed by Judge Maryellen Noreika on 6/16/2023. (dlw) (Entered: 06/16/2023) (2) |
| Jun 16, 2023 | 8 | NOTICE of Appearance by Dominick T. Gattuso on behalf of Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. (Gattuso, Dominick) (Entered: 06/16/2023) (1) |
| Jun 16, 2023 | 7 | Joint STIPULATION Waiving Service and Setting Deadline to Respond to the Complaint by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Hoeschen, Nathan) (Entered: 06/16/2023) (2) |
| Jun 14, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 06/14/2023) (0) |
| Jun 7, 2023 | 6 | Summons Issued as to Dr. Reddys Laboratories, Inc. on 6/7/2023; Dr. Reddys Laboratories, Ltd. on 6/7/2023. (Attachments: # 1 Summons Issued)(mpb) (Entered: 06/07/2023) (Summons Issued) (2) |
| Jun 7, 2023 | 1 | COMPLAINT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ( Filing fee $ 402, receipt number ADEDC-4153448.) - filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 06/07/2023) (Civil Cover Sheet) (2) |
| Jun 7, 2023 | 1 | COMPLAINT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ( Filing fee $ 402, receipt number ADEDC-4153448.) - filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 06/07/2023) (Exhibit A) (25) |
| Jun 7, 2023 | 6 | Summons Issued as to Dr. Reddys Laboratories, Inc. on 6/7/2023; Dr. Reddys Laboratories, Ltd. on 6/7/2023. (Attachments: # 1 Summons Issued)(mpb) (Entered: 06/07/2023) (Main Document) (2) |
| Jun 7, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Horizon Therapeutics Capital Limited, Corporate Parent Horizon Therapeutics Finance Sarl for Horizon Therapeutics USA Inc.; Corporate Parent Horizon Therapeutics Holdings Limited for Horizon Therapeutics Ireland DAC filed by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (mpb) (Entered: 06/07/2023) (2) |
| Jun 7, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,504,699 B2. (mpb) (Entered: 06/07/2023) (1) |
| Jun 7, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/26/2023. Date of Expiration of Patent: 8/3/2023.Thirty Month Stay Deadline: 10/26/2025. (mpb) (Entered: 06/07/2023) (1) |
| Jun 7, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 06/07/2023) (3) |
| Jun 7, 2023 | 1 | COMPLAINT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ( Filing fee $ 402, receipt number ADEDC-4153448.) - filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 06/07/2023) (Main Document) (10) |
